Mutational and selective effects on copy-number variants in the human genome

2007 ◽  
Vol 39 (S7) ◽  
pp. S22-S29 ◽  
Author(s):  
Gregory M Cooper ◽  
Deborah A Nickerson ◽  
Evan E Eichler
2008 ◽  
Vol 18 (12) ◽  
pp. 1865-1874 ◽  
Author(s):  
P. M. Kim ◽  
H. Y.K. Lam ◽  
A. E. Urban ◽  
J. O. Korbel ◽  
J. Affourtit ◽  
...  

2007 ◽  
Vol 104 (24) ◽  
pp. 10110-10115 ◽  
Author(s):  
J. O. Korbel ◽  
A. E. Urban ◽  
F. Grubert ◽  
J. Du ◽  
T. E. Royce ◽  
...  

2013 ◽  
Vol 202 (1) ◽  
pp. 5-6 ◽  
Author(s):  
David St Clair

SummaryCopy number variants are small chromosomal deletions and duplications. When they alter the dose of genes critical for normal brain development and adult brain functioning they may cause severe disorders such as autism and schizophrenia. Numerous such loci have recently been identified. They are offering amazing leads for neuropsychiatric research.


2007 ◽  
Vol 9 (9) ◽  
pp. 600-606 ◽  
Author(s):  
Laia Rodriguez-Revenga ◽  
Montserrat Mila ◽  
Carla Rosenberg ◽  
Allen Lamb ◽  
Charles Lee

2014 ◽  
Vol 29 (S3) ◽  
pp. 541-541
Author(s):  
A. Dahdouh ◽  
F. Bena ◽  
J. Prados ◽  
M. Taleb ◽  
A. Malafosse

De nombreuses études ont affirmé l’association significative des Copy Number Variants (CNVs) aux troubles psychotiques et de l’humeur, remettant en question l’hypothèse « maladie commune-variants communs » pour un modèle « maladie commune-variants rares » [1]. Par ailleurs, plusieurs études ont montré l’association de même CNVs à des pathologies différentes telles que l’autisme, le trouble bipolaire, le retard mental ou l’épilepsie, ce qui suggère un effet pléiotropique de ces mutations qui pourrait conduire à reconsidérer la nosologie actuelle. Enfin, certains de ces CNVs apparaîtraient de novo, mais il existe peu d’études familiales, et aucune effectuée sur des pedigrees étendus pour préciser les relations génotype-phénotype au sein des familles [2]. Dans ce travail nous avons étudié une famille consanguine multi-générationnelle et multiplexe pour le phénotype de trouble bipolaire de type I et de schizophrénie ; identifiée dans la région de Tlemcen au nord ouest de l’Algérie. Une recherche pangénomique de CNVs utilisant le Kit 44 K Agilent Human Genome CGH Microarray, a été achevée pour quatre sujets dont deux atteints et deux sains. Cette analyse a permis de mettre en évidence la duplication 16p13.33 en position 3863532-3927262 (Hg19), qui présente un caractère de novo chez une patiente, car absente chez ses deux parents. La duplication de la région chromosomique 16p13.3 affectant le gène CREBBP dont la délétion et/ou la mutation est incriminée dans le syndrome de Rubinstein-Taybi est actuellement décrite dans une entité syndromique regroupant dysmorphie de la face, retard mental léger à moyen, croissance normale, arthrogrypose, anomalies orthopédiques des extrémités surtout des mains et des anomalies de développement cardiaque, génital et oculaire [3]. Ce CNV n’a jamais été décrit précédemment dans le phénotype de trouble bipolaire ; dans ce travail nous présentons une nouvelle description génotype-phénotype d’une dup16p13.33 de novo, dans le trouble bipolaire type I.


Author(s):  
Anna Benet-Pagès ◽  
Kate Rosenbloom ◽  
Luis Nassar ◽  
Christopher Lee ◽  
Brian Raney ◽  
...  

The UCSC Genome Browser has been an important tool for genomics and clinical genetics since the sequence of the human genome was first released in 2000. As it has grown in scope to display more types of data it has also grown more complicated. The data, which are dispersed at many locations worldwide, are collected into one view on the Browser, where the graphical interface presents the data in one location. This supports the expertise of the researcher to interpret variants in the genome. Because the analysis of Single Nucleotide Variants (SNVs) and Copy Number Variants (CNVs) require interpretation of data at very different genomic scales, different data resources are required. We present here several Recommended Track Sets designed to facilitate the interpretation of variants in the clinic, offering quick access to datasets relevant to the appropriate scale.


2019 ◽  
Vol 1 (1) ◽  
pp. 6-12
Author(s):  
Fatima Javeria ◽  
Shazma Altaf ◽  
Alishah Zair ◽  
Rana Khalid Iqbal

Schizophrenia is a severe mental disease. The word schizophrenia literally means split mind. There are three major categories of symptoms which include positive, negative and cognitive symptoms. The disease is characterized by symptoms of hallucination, delusions, disorganized thinking and speech. Schizophrenia is related to many other mental and psychological problems like suicide, depression, hallucinations. Including these, it is also a problem for the patient’s family and the caregiver. There is no clear reason for the disease, but with the advances in molecular genetics; certain epigenetic mechanisms are involved in the pathophysiology of the disease. Epigenetic mechanisms that are mainly involved are the DNA methylation, copy number variants. With the advent of GWAS, a wide range of SNPs is found linked with the etiology of schizophrenia. These SNPs serve as ‘hubs’; because these all are integrating with each other in causing of schizophrenia risk. Until recently, there is no treatment available to cure the disease; but anti-psychotics can reduce the disease risk by minimizing its symptoms. Dopamine, serotonin, gamma-aminobutyric acid, are the neurotransmitters which serve as drug targets in the treatment of schizophrenia. Due to the involvement of genetic and epigenetic mechanisms, drugs available are already targeting certain genes involved in the etiology of the disease.


2020 ◽  
Author(s):  
◽  
Evelina Siavrienė

A Molecular and Functional Evaluation of Coding and Non-Coding Genome Sequence Variants and Copy Number Variants


2016 ◽  
Vol 94 (suppl_5) ◽  
pp. 146-146
Author(s):  
D. M. Bickhart ◽  
L. Xu ◽  
J. L. Hutchison ◽  
J. B. Cole ◽  
D. J. Null ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document